Dr. Kardosh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3181 SW Sam Jackson Park Rd
Portland, OR 97239Phone+1 503-494-8534Fax+1 503-494-3257- Is this information wrong?
Summary
- Dr. Adel Kardosh is an oncologist in Portland, OR. He received his medical degree from Keck School of Medicine of USC and completed Oncology fellowship at Stanford University. He has been in practice 6 years. He specializes in gastrointestinal cancer.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 2017
University of Southern California/LAC+USC Medical CenterResidency, Internal Medicine, 2011 - 2014
Keck School of Medicine of the University of Southern CaliforniaClass of 2011
Keck School of Medicine PhD, Molecular Biology and Immunology , 2002 - 2007
Certifications & Licensure
OR State Medical License 2018 - 2025
CA State Medical License 2012 - 2024- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Updated Management of Colorectal Cancer Liver Metastases: Scientific Advances Driving Modern Therapeutic Innovations.Ranish K Patel, Shahrose Rahman, Issac R Schwantes, Alexandra Bartlett, Robert Eil, Khashayar Farsad, Kathryn Fowler, Shaun M Goodyear, Lissi Hansen, Adel Kardosh, Nim...> ;Cellular and Molecular Gastroenterology and Hepatology. 2023 Jan 1
- Phase 2 study of preoperative chemotherapy with nab-paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node-positive pancreatic ductal ...Emerson Y Chen, Adel Kardosh, Nima Nabavizadeh, Bryan Foster, Skye C Mayo, Kevin G Billingsley, Erin W Gilbert, Christian Lanciault, Aaron Grossberg, Kenneth G Bensch,...> ;Cancer Medicine. 2023 Jun 1
- 25 citationsTucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-la...John H Strickler, Andrea Cercek, Salvatore Siena, Thierry André, Kimmie Ng, Eric Van Cutsem, Christina Wu, Andrew S Paulson, Joleen M Hubbard, Andrew L Coveler, Christ...> ;The Lancet. Oncology. 2023 May 1
- Join now to see all
Press Mentions
New Treatment Strategy Aims to Stop Rare Liver CancerJune 15th, 2022
Professional Memberships
- Member
Hospital Affiliations
OHSU HospitalPortland, Oregon
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
